Dr. Rami Aqeilan

Senior Lecturer at the Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research-IMRIC , Immunology and Cancer Research, IMRIC
IMRIC Researcher

Share this
Why I became a researcher: 

Since earning my BSc I have felt nothing is more important than helping people to fight cancer.

My PhD studies paved the road and since then I decided to join that fight and contribute to conquer cancer.

Studying the molecular aspect of cancer biology aims to uncover the genes (coding and non-coding) that contribute to transforming an incipient cell. Genes, tumor suppressors or oncogenes, are key players in this process. Their inactivation or activation, respectively, is a hallmark of almost all cancers. Learning how do these genes work is very important for treatment and diagnosis of cancer.

Education: 

2002-2004: Thomas Jefferson University, Philadelphia PA

2002: PhD in Cellular Biochemistry and Human Genetics, Hebrew University

2002-2004: Post-Doctoral training, Thomas Jefferson University, Philadelphia, PA

2002: PhD in Cellular Biochemistry and Human Genetics, Hebrew University

1996: BSc in Biological Sciences, University of Jordan

Selected Awards and Honors: 
2011: Development and Research Award, Israeli Cancer Research Funds (ICRF)
2010: Excellence Research Award from the Faculty of Medicine, Hebrew University-Hadassah Medical School
2010: Israeli Cancer Association Excellence Award
2008: Development and Research Award, Israeli Cancer Research Funds (ICRF)
2008

: Bergman 
Memorial
 Research
 Award

2008

: Ma’of Award for Outstanding Young Scientists by the Israeli Council for Higher Education (Covers PI’s Salary for 3 years)
2006: First
 Prize
 Award
 for
 the
 best
 presentation
 in
 the
 Second
 Israeli American
 Joint
 meeting 
on 
Cancer
2005



: Sidney
 Kimmel 
Scholar
 Award
 for
 Cancer
 Research
($200,000)
2001
: The
 Hebrew University 
Scholarship 
of
 Excellence

2001: Luxembourg
 Scholarship 
for
 Graduate
 Students‐Hebrew University
Contact: 
ramiaq [at] ekmd [dot] huji [dot] ac [dot] il
Related Videos

Cancer Research Hub Day: IMRIC PhD Student Mohammed

Your rating: None Average: 5 (1 vote)
Researcher in the News

New Grant Funds IMRIC Research On Role Of MicroRNAs In Osteosarcoma Development And Progression

The Liddy Shriver Sarcoma Initiative has partnered with the Alan B. Slifka Foundation to fund a $62,500 grant for promising osteosarcoma research at the Hebrew University of Jerusalem’s Faculty of Medicine. In the study, Prof. Rami Aqeilan and his research team will explore pre-treatment biomarkers of osteosarcoma metastasis and their responsiveness to therapy.